Evidence map›Paper›PMID 24032673›Full record

ArticleThe Biochemical journal2013

Dynamic conformational switching in the chemokine ligand is essential for G-protein-coupled receptor activation.

Prem Raj B Joseph, Kirti V Sawant, Angela Isley, Mesias Pedroza, Roberto P Garofalo, Ricardo M Richardson, Krishna Rajarathnam

Abstract read
In one paragraph

Article in The Biochemical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Structure basis for C-C chemokine receptor 4 modulation by orthosteric and allosteric antagonists.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.International journal of molecular sciences · 2023
    Review
  3. Latest update on chemokine receptors as therapeutic targets.Biochemical Society transactions · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Glycosaminoglycan Interactions Fine-Tune Chemokine-Mediated Neutrophil Trafficking: Structural Insights and Molecular Mechanisms.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Prem Raj B Joseph*Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1055, U.S.A.
Kirti V Sawant
Angela Isley
Mesias Pedroza
Roberto P Garofalo
Ricardo M Richardson
Krishna Rajarathnam
The University of Texas Medical Branch at Galveston · USNorth Carolina Central University · US

Funding

Therapeutic assessment of synthetic heparin sulfates in transplantation modelsP01HL107152 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI DESAI, UMESH RAMANLAL · 2011 to 2017
$15.8M
Regulation of Chemokine Mediated Leukocyte FunctionsR01AI038910 · NIAID · NORTH CAROLINA CENTRAL UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 2002 to 2011
$2.3M
Role of chemokine monomer-dimer equilibrium in innate immunity and inflammationR01AI069152 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJARATHNAM, KRISHNA · 2006 to 2011
$1.9M
Chemokine CXCL17 and Mucosal ImmunosurveillanceR21AI097975 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJARATHNAM, KRISHNA · 2012 to 2013
$407k
REGULATION OF HUMAN INTERLEUKIN-8 RECEPTORSR29AI038910 · NIAID · DUKE UNIVERSITY · PI RICHARDSON, MICHELER RICARDO · 1996 to 2000
$107k
NHLBI NIH HHS P01 HL107152NIAID NIH HHS AI38910NIAID NIH HHS R01 AI038910NIAID NIH HHS R01 AI069152NIAID NIH HHS R21 AI097975NIAID NIH HHS R29 AI038910
6 · The paper itself

Abstract

Chemokines mediate diverse functions from organogenesis to mobilizing leucocytes, and are unusual agonists for class-A GPCRs (G-protein-coupled receptors) because of their large size and multi-domain structure. The current model for receptor activation, which involves interactions between chemokine N-loop and receptor N-terminal residues (Site-I) and between chemokine N-terminal and receptor extracellular loop/transmembrane residues (Site-II), fails to describe differences in ligand/receptor selectivity and the activation of multiple signalling pathways. In the present study, we show in neutrophil-activating chemokine CXCL8 that the highly conserved GP (glycine-proline) motif located distal to both N-terminal and N-loop residues couples Site-I and Site-II interactions. GP mutants showed large differences from native-like to complete loss of function that could not be correlated with the specific mutation, receptor affinity or subtype, or a specific signalling pathway. NMR studies indicated that the GP motif does not influence Site-I interactions, but molecular dynamics simulations suggested that this motif dictates substates of the CXCL8 conformational ensemble. We conclude that the GP motif enables diverse receptor functions by controlling cross-talk between Site-I and Site-II, and further propose that the repertoire of chemokine functions is best described by a conformational ensemble model in which a network of long-range coupled indirect interactions mediate receptor activity.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsBinding SitesCalcium SignalingCell LineConserved SequenceFemaleInterleukin-8LigandsMiceMice, Inbred BALB CMolecular Dynamics SimulationMolecular Sequence DataNeutrophilsProtein BindingInterleukin-8LigandsReceptors, Interleukin-8AReceptors, Interleukin-8B

Identifiers

PMID24032673
PMCPMC4157346
OpenAlexW2049635911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.